Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events among those treated with zanubrutinib compared with ibrutinib.

Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says. The antibiotic ...

A new study reveals that low-dose antibiotics can effectively treat lymphocytic scarring alopecia, a rare hair loss condition ...

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that affects white blood cells. Survival rates tend to be high, but these may vary. Leukemia is a type of cancer involving human blood ...

Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for CLL and ...

Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says.The antibi ...

A new study suggests that small doses of a widely used antibiotic and anti-inflammatory drug could effectively treat a rare ...

Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Small amounts of a common antibiotic and anti-inflammatory drug can help treat a rare hair loss problem caused by a misplaced ...